Sue Caleo

598 total citations
22 papers, 500 citations indexed

About

Sue Caleo is a scholar working on Economics and Econometrics, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sue Caleo has authored 22 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 8 papers in Psychiatry and Mental health and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sue Caleo's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Schizophrenia research and treatment (5 papers) and Epilepsy research and treatment (3 papers). Sue Caleo is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Schizophrenia research and treatment (5 papers) and Epilepsy research and treatment (3 papers). Sue Caleo collaborates with scholars based in Belgium, United States and Australia. Sue Caleo's co-authors include Philip M. Alberti, Lawrence H. Yang, Mark Opler, David Mallett, Jasmina Ivanova, Howard G. Birnbaum, Yohanne Kidolezi, Erik Buskens, Bart Heeg and Jane Hall and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Epilepsia.

In The Last Decade

Sue Caleo

21 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sue Caleo Belgium 14 251 137 134 75 71 22 500
Jan McKendrick United States 13 247 1.0× 33 0.2× 74 0.6× 44 0.6× 64 0.9× 26 640
Amy R. Pettit United States 13 292 1.2× 45 0.3× 260 1.9× 68 0.9× 158 2.2× 30 822
Bruce Wong United States 8 254 1.0× 29 0.2× 69 0.5× 77 1.0× 78 1.1× 16 428
Élodie Pambrun France 16 213 0.8× 82 0.6× 24 0.2× 26 0.3× 70 1.0× 40 643
Erica C.G. van Geffen Netherlands 14 127 0.5× 60 0.4× 103 0.8× 10 0.1× 69 1.0× 20 580
Ramón Sabés-Figuera United Kingdom 12 146 0.6× 34 0.2× 102 0.8× 21 0.3× 132 1.9× 23 498
Lynne E. Way United States 9 505 2.0× 25 0.2× 113 0.8× 133 1.8× 89 1.3× 10 873
Soumitra Shankar Datta India 15 186 0.7× 125 0.9× 27 0.2× 13 0.2× 125 1.8× 59 585
Steven Burch United States 12 232 0.9× 61 0.4× 159 1.2× 5 0.1× 45 0.6× 17 615
Pia von Blanckenburg Germany 14 93 0.4× 101 0.7× 30 0.2× 23 0.3× 122 1.7× 48 635

Countries citing papers authored by Sue Caleo

Since Specialization
Citations

This map shows the geographic impact of Sue Caleo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Caleo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Caleo more than expected).

Fields of papers citing papers by Sue Caleo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Caleo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Caleo. The network helps show where Sue Caleo may publish in the future.

Co-authorship network of co-authors of Sue Caleo

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Caleo. A scholar is included among the top collaborators of Sue Caleo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Caleo. Sue Caleo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmitz, Bettina, Georgia Montouris, Barbara Schäuble, & Sue Caleo. (2010). Assessing the unmet treatment need in partial‐onset epilepsy: Looking beyond seizure control. Epilepsia. 51(11). 2231–2240. 21 indexed citations
2.
Ivanova, Jasmina, Howard G. Birnbaum, Yohanne Kidolezi, et al.. (2010). Economic Burden of Epilepsy among the Privately Insured in the US. PharmacoEconomics. 28(8). 675–685. 54 indexed citations
3.
Ivanova, Jasmina, Howard G. Birnbaum, Yohanne Kidolezi, et al.. (2009). Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Epilepsia. 51(5). 838–844. 45 indexed citations
4.
Heeg, Bart, Erik Buskens, Marc Botteman, et al.. (2008). The Cost-Effectiveness of Atypicals in the UK. Value in Health. 11(7). 1007–1021. 22 indexed citations
5.
Heeg, Bart, et al.. (2008). Modelling Approaches. PharmacoEconomics. 26(8). 633–648. 40 indexed citations
6.
Birnbaum, HG, Jasmina Ivanova, Yohanne Kidolezi, & Sue Caleo. (2008). PND15 THE INDIRECT COST BURDEN OF EPILEPSY IN THE UNITED STATES. Value in Health. 11(6). A604–A604. 1 indexed citations
7.
Birnbaum, HG, Jasmina I. Ivanova, Yohanne Kidolezi, & Sue Caleo. (2008). PND11 EPILEPSY COST OF ILLNESS IN THE U.S. PRIVATELY INSURED. Value in Health. 11(6). A602–A603. 1 indexed citations
8.
Opler, Mark, Lawrence H. Yang, Sue Caleo, & Philip M. Alberti. (2007). Statistical validation of the criteria for symptom remission in schizophrenia: Preliminary findings. BMC Psychiatry. 7(1). 35–35. 70 indexed citations
9.
10.
Heeg, Bart, José Leopoldo Ferreira Antunes, Maria Luísa Figueira, et al.. (2007). Cost-effectiveness and budget impact of long-acting risperidone in Portugal: a modeling exercise. Current Medical Research and Opinion. 24(2). 349–358. 14 indexed citations
11.
Graeve, Diana De, et al.. (2005). Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis. PharmacoEconomics. 23(S1). 35–47. 46 indexed citations
12.
Caleo, Sue, et al.. (2005). PMH59 THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY—E-STAR: BASELINE RESULTS FOR GERMANY, SPAIN AND AUSTRALIA. Value in Health. 8(3). 403–403. 1 indexed citations
13.
Ingham, M., et al.. (2005). PMH20 RELATION BETWEEN SYMPTOMS IN SCHIZOPHRENIA AND RISK OF HARM TO SELF AND OTHERS. Value in Health. 8(6). A201–A202. 1 indexed citations
14.
Tjan‐Heijnen, Vivianne C. G., Sue Caleo, Pieter E. Postmus, et al.. (2003). Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923). Annals of Oncology. 14(2). 248–257. 19 indexed citations
15.
16.
Neymark, Niels, et al.. (2001). Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer. European Journal of Cancer. 37(14). 1768–1774. 16 indexed citations
17.
King, Madeleine, Jane Hall, Sue Caleo, Howard Gurney, & Paul R. Harnett. (2000). Home or Hospital? An Evaluation of the Costs, Preferences, and Outcomes of Domiciliary Chemotherapy. International Journal of Health Services. 30(3). 557–579. 48 indexed citations
18.
19.
Caleo, Sue, et al.. (1998). Measles elimination: Costing of a national measles immunisation 'catch up' program, CHERE Project Report No 7. Kagoshima Daigaku Kogakubu Kenkyu Hokoku. 1 indexed citations
20.
Caleo, Sue, et al.. (1996). Clinical evaluation of community pharmacists' interventions. International Journal of Pharmacy Practice. 4(4). 221–227. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan McKendrick Breakdown of academic impact, for papers by Amy R. Pettit Breakdown of academic impact, for papers by Bruce Wong Breakdown of academic impact, for papers by Élodie Pambrun Breakdown of academic impact, for papers by Erica C.G. van Geffen Breakdown of academic impact, for papers by Ramón Sabés-Figuera Breakdown of academic impact, for papers by Lynne E. Way Breakdown of academic impact, for papers by Soumitra Shankar Datta Breakdown of academic impact, for papers by Steven Burch Breakdown of academic impact, for papers by Pia von Blanckenburg
Rankless by CCL
2026